Update to Notice to Investors - IGC Pharma, INC.

Press

Releases

June 24, 2020

Update to Notice to Investors

Related Posts

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25”

March 12, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the “Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results”

March 10, 2025

IGC Pharma Expands AI Platform with Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

March 4, 2025

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024